Univercells Technologies, a Donaldson Life Sciences business Email Format
Biotechnology ResearchWallonia, Belgium51-200 Employees
Univercells Technologies is a mid-sized biotechnology firm based in Nivelles, Wallonia, Belgium, that provides biomanufacturing technologies aimed at cost-efficient viral vector and vaccine production from research to commercial scale. Its offerings emphasize process intensification and a linked manufacturing approach to meet growing demand for viral vectors and viral vaccines, with the aim of improving performance while reducing footprint and costs. The company serves researchers and manufacturers in the life sciences sector on a global basis. The company was incorporated in 2020 with backing from the Univercells group and now operates as a Donaldson Life Sciences business. In June 2026, its chief executive departed; the organization continues under the Donaldson Life Sciences umbrella.